Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions

The cytochromes P450 (CYPs) comprise a vast superfamily of enzymes found in virtually all life forms. In mammals, xenobiotic metabolizing CYPs provide crucial protection from the effects of exposure to a wide variety of chemicals, including environmental toxins and therapeutic drugs. Ideally, the in...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2008-03, Vol.153 (S1), p.S82-S89
Main Authors: Maréchal, J‐D, Kemp, C A, Roberts, G C K, Paine, M J I, Wolf, C R, Sutcliffe, M J
Format: Article
Language:English
Subjects:
Animals
comparative modelling
CYP2D6
Cytochrome P-450 CYP2D6 - chemistry
Cytochrome P-450 CYP2D6 - drug effects
Cytochrome P-450 Enzyme System - chemistry
Cytochrome P-450 Enzyme System - drug effects
Cytochrome P-450 Enzyme System - metabolism
cytochromes P450
docking
Drug Interactions
drug metabolism
homology modelling
Humans
hypothesis‐driven studies
Models, Molecular
Pharmaceutical Preparations - metabolism
Review
Substrate Specificity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3
cites cdi_FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3
container_end_page S89
container_issue S1
container_start_page S82
container_title British journal of pharmacology
container_volume 153
creator Maréchal, J‐D
Kemp, C A
Roberts, G C K
Paine, M J I
Wolf, C R
Sutcliffe, M J
description The cytochromes P450 (CYPs) comprise a vast superfamily of enzymes found in virtually all life forms. In mammals, xenobiotic metabolizing CYPs provide crucial protection from the effects of exposure to a wide variety of chemicals, including environmental toxins and therapeutic drugs. Ideally, the information on the possible metabolism by CYPs required during drug development would be obtained from crystal structures of all the CYPs of interest. For some years only crystal structures of distantly related bacterial CYPs were available and homology modelling techniques were used to bridge the gap and produce structural models of human CYPs, and thereby obtain useful functional information. A significant step forward in the reliability of these models came seven years ago with the first crystal structure of a mammalian CYP, rabbit CYP2C5, followed by the structures of six human enzymes, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2D6 and CYP3A4, and a second rabbit enzyme, CYP2B4. In this review we describe as a case study the evolution of a CYP2D6 model, leading to the validation of the model as an in silico tool for predicting binding and metabolism. This work has led directly to the successful design of CYP2D6 mutants with novel activity—including creating a testosterone hydroxylase, converting quinidine from inhibitor to substrate, creating a diclofenac hydroxylase and creating a dextromethorphan O‐demethylase. Our modelling‐derived hypothesis‐driven integrated interdisciplinary studies have given key insight into the molecular determinants of CYP2D6 and other important drug metabolizing enzymes. British Journal of Pharmacology (2008) 153, S82–S89; doi:10.1038/sj.bjp.0707570; published online 19 November 2007
doi_str_mv 10.1038/sj.bjp.0707570
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2268062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1438865971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3</originalsourceid><addsrcrecordid>eNqFkbuO1DAYhS0EYoeFlhJZVDQZftvxJQ0SDJddaSWmgILKcmxnxlESD3YCmo5H4Bl5Egwz4tZQ2dL5_MlHB6GHBNYEmHqa-3XbH9YgQXIJt9CK1FJUnClyG60AQFaEKHWB7uXcA5RQ8rvogiiggtBmhbrrKYfdfs44THPELi07PPrZtHEIecTtEdvjHO0-xdFnvK054K7c8RidH4Yw7XCeFxdKFju8-bClL8W3L19_aorQJ2PnEKd8H93pzJD9g_N5id6_fvVuc1XdvH1zvXl-U9m6IaJqKLHOSc5rYQy3pDMOKFiwLVeM1mC5F5wb3zhqGmFt03WOtS0wVisnTMcu0bOT97C0o3fWT3Mygz6kMJp01NEE_Xcyhb3exU-aUqFA0CJ4chak-HHxedZjyLZUNZOPS9aEcdFQISQU9PE_aB-XNJV6mhJJoZGKFGh9gmyKOSff_foLAf1jQZ17XRbU5wXLg0d_NviNnycrAD0Bn8Pgj__R6RfbK1UL9h19SapF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217209781</pqid></control><display><type>article</type><title>Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions</title><source>Wiley-Blackwell Journals</source><source>PubMed (Medline)</source><creator>Maréchal, J‐D ; Kemp, C A ; Roberts, G C K ; Paine, M J I ; Wolf, C R ; Sutcliffe, M J</creator><creatorcontrib>Maréchal, J‐D ; Kemp, C A ; Roberts, G C K ; Paine, M J I ; Wolf, C R ; Sutcliffe, M J</creatorcontrib><description>The cytochromes P450 (CYPs) comprise a vast superfamily of enzymes found in virtually all life forms. In mammals, xenobiotic metabolizing CYPs provide crucial protection from the effects of exposure to a wide variety of chemicals, including environmental toxins and therapeutic drugs. Ideally, the information on the possible metabolism by CYPs required during drug development would be obtained from crystal structures of all the CYPs of interest. For some years only crystal structures of distantly related bacterial CYPs were available and homology modelling techniques were used to bridge the gap and produce structural models of human CYPs, and thereby obtain useful functional information. A significant step forward in the reliability of these models came seven years ago with the first crystal structure of a mammalian CYP, rabbit CYP2C5, followed by the structures of six human enzymes, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2D6 and CYP3A4, and a second rabbit enzyme, CYP2B4. In this review we describe as a case study the evolution of a CYP2D6 model, leading to the validation of the model as an in silico tool for predicting binding and metabolism. This work has led directly to the successful design of CYP2D6 mutants with novel activity—including creating a testosterone hydroxylase, converting quinidine from inhibitor to substrate, creating a diclofenac hydroxylase and creating a dextromethorphan O‐demethylase. Our modelling‐derived hypothesis‐driven integrated interdisciplinary studies have given key insight into the molecular determinants of CYP2D6 and other important drug metabolizing enzymes. British Journal of Pharmacology (2008) 153, S82–S89; doi:10.1038/sj.bjp.0707570; published online 19 November 2007</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0707570</identifier><identifier>PMID: 18026129</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; comparative modelling ; CYP2D6 ; Cytochrome P-450 CYP2D6 - chemistry ; Cytochrome P-450 CYP2D6 - drug effects ; Cytochrome P-450 Enzyme System - chemistry ; Cytochrome P-450 Enzyme System - drug effects ; Cytochrome P-450 Enzyme System - metabolism ; cytochromes P450 ; docking ; Drug Interactions ; drug metabolism ; homology modelling ; Humans ; hypothesis‐driven studies ; Models, Molecular ; Pharmaceutical Preparations - metabolism ; Review ; Substrate Specificity</subject><ispartof>British journal of pharmacology, 2008-03, Vol.153 (S1), p.S82-S89</ispartof><rights>2008 British Pharmacological Society</rights><rights>Copyright Nature Publishing Group Mar 2008</rights><rights>Copyright © 2008 Nature Publishing Group 2008 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3</citedby><cites>FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1038%2Fsj.bjp.0707570$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1038%2Fsj.bjp.0707570$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,733,786,790,891,1424,27957,27958,45609,45610,50923,51032,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18026129$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maréchal, J‐D</creatorcontrib><creatorcontrib>Kemp, C A</creatorcontrib><creatorcontrib>Roberts, G C K</creatorcontrib><creatorcontrib>Paine, M J I</creatorcontrib><creatorcontrib>Wolf, C R</creatorcontrib><creatorcontrib>Sutcliffe, M J</creatorcontrib><title>Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>The cytochromes P450 (CYPs) comprise a vast superfamily of enzymes found in virtually all life forms. In mammals, xenobiotic metabolizing CYPs provide crucial protection from the effects of exposure to a wide variety of chemicals, including environmental toxins and therapeutic drugs. Ideally, the information on the possible metabolism by CYPs required during drug development would be obtained from crystal structures of all the CYPs of interest. For some years only crystal structures of distantly related bacterial CYPs were available and homology modelling techniques were used to bridge the gap and produce structural models of human CYPs, and thereby obtain useful functional information. A significant step forward in the reliability of these models came seven years ago with the first crystal structure of a mammalian CYP, rabbit CYP2C5, followed by the structures of six human enzymes, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2D6 and CYP3A4, and a second rabbit enzyme, CYP2B4. In this review we describe as a case study the evolution of a CYP2D6 model, leading to the validation of the model as an in silico tool for predicting binding and metabolism. This work has led directly to the successful design of CYP2D6 mutants with novel activity—including creating a testosterone hydroxylase, converting quinidine from inhibitor to substrate, creating a diclofenac hydroxylase and creating a dextromethorphan O‐demethylase. Our modelling‐derived hypothesis‐driven integrated interdisciplinary studies have given key insight into the molecular determinants of CYP2D6 and other important drug metabolizing enzymes. British Journal of Pharmacology (2008) 153, S82–S89; doi:10.1038/sj.bjp.0707570; published online 19 November 2007</description><subject>Animals</subject><subject>comparative modelling</subject><subject>CYP2D6</subject><subject>Cytochrome P-450 CYP2D6 - chemistry</subject><subject>Cytochrome P-450 CYP2D6 - drug effects</subject><subject>Cytochrome P-450 Enzyme System - chemistry</subject><subject>Cytochrome P-450 Enzyme System - drug effects</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>cytochromes P450</subject><subject>docking</subject><subject>Drug Interactions</subject><subject>drug metabolism</subject><subject>homology modelling</subject><subject>Humans</subject><subject>hypothesis‐driven studies</subject><subject>Models, Molecular</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Review</subject><subject>Substrate Specificity</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkbuO1DAYhS0EYoeFlhJZVDQZftvxJQ0SDJddaSWmgILKcmxnxlESD3YCmo5H4Bl5Egwz4tZQ2dL5_MlHB6GHBNYEmHqa-3XbH9YgQXIJt9CK1FJUnClyG60AQFaEKHWB7uXcA5RQ8rvogiiggtBmhbrrKYfdfs44THPELi07PPrZtHEIecTtEdvjHO0-xdFnvK054K7c8RidH4Yw7XCeFxdKFju8-bClL8W3L19_aorQJ2PnEKd8H93pzJD9g_N5id6_fvVuc1XdvH1zvXl-U9m6IaJqKLHOSc5rYQy3pDMOKFiwLVeM1mC5F5wb3zhqGmFt03WOtS0wVisnTMcu0bOT97C0o3fWT3Mygz6kMJp01NEE_Xcyhb3exU-aUqFA0CJ4chak-HHxedZjyLZUNZOPS9aEcdFQISQU9PE_aB-XNJV6mhJJoZGKFGh9gmyKOSff_foLAf1jQZ17XRbU5wXLg0d_NviNnycrAD0Bn8Pgj__R6RfbK1UL9h19SapF</recordid><startdate>200803</startdate><enddate>200803</enddate><creator>Maréchal, J‐D</creator><creator>Kemp, C A</creator><creator>Roberts, G C K</creator><creator>Paine, M J I</creator><creator>Wolf, C R</creator><creator>Sutcliffe, M J</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>200803</creationdate><title>Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions</title><author>Maréchal, J‐D ; Kemp, C A ; Roberts, G C K ; Paine, M J I ; Wolf, C R ; Sutcliffe, M J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>comparative modelling</topic><topic>CYP2D6</topic><topic>Cytochrome P-450 CYP2D6 - chemistry</topic><topic>Cytochrome P-450 CYP2D6 - drug effects</topic><topic>Cytochrome P-450 Enzyme System - chemistry</topic><topic>Cytochrome P-450 Enzyme System - drug effects</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>cytochromes P450</topic><topic>docking</topic><topic>Drug Interactions</topic><topic>drug metabolism</topic><topic>homology modelling</topic><topic>Humans</topic><topic>hypothesis‐driven studies</topic><topic>Models, Molecular</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Review</topic><topic>Substrate Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maréchal, J‐D</creatorcontrib><creatorcontrib>Kemp, C A</creatorcontrib><creatorcontrib>Roberts, G C K</creatorcontrib><creatorcontrib>Paine, M J I</creatorcontrib><creatorcontrib>Wolf, C R</creatorcontrib><creatorcontrib>Sutcliffe, M J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maréchal, J‐D</au><au>Kemp, C A</au><au>Roberts, G C K</au><au>Paine, M J I</au><au>Wolf, C R</au><au>Sutcliffe, M J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2008-03</date><risdate>2008</risdate><volume>153</volume><issue>S1</issue><spage>S82</spage><epage>S89</epage><pages>S82-S89</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><notes>Current address: Departament de Química, Universitat Autònoma de Barcelona, Barcelona, Spain.</notes><notes>Current address: Liverpool School of Tropical Medicine, University of Liverpool, Liverpool, UK.</notes><notes>The bulk of the work described herein was carried out while these authors were at the Departments of Biochemistry and Chemistry, University of Leicester, Leicester, UK.</notes><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-1</notes><notes>content type line 23</notes><abstract>The cytochromes P450 (CYPs) comprise a vast superfamily of enzymes found in virtually all life forms. In mammals, xenobiotic metabolizing CYPs provide crucial protection from the effects of exposure to a wide variety of chemicals, including environmental toxins and therapeutic drugs. Ideally, the information on the possible metabolism by CYPs required during drug development would be obtained from crystal structures of all the CYPs of interest. For some years only crystal structures of distantly related bacterial CYPs were available and homology modelling techniques were used to bridge the gap and produce structural models of human CYPs, and thereby obtain useful functional information. A significant step forward in the reliability of these models came seven years ago with the first crystal structure of a mammalian CYP, rabbit CYP2C5, followed by the structures of six human enzymes, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2D6 and CYP3A4, and a second rabbit enzyme, CYP2B4. In this review we describe as a case study the evolution of a CYP2D6 model, leading to the validation of the model as an in silico tool for predicting binding and metabolism. This work has led directly to the successful design of CYP2D6 mutants with novel activity—including creating a testosterone hydroxylase, converting quinidine from inhibitor to substrate, creating a diclofenac hydroxylase and creating a dextromethorphan O‐demethylase. Our modelling‐derived hypothesis‐driven integrated interdisciplinary studies have given key insight into the molecular determinants of CYP2D6 and other important drug metabolizing enzymes. British Journal of Pharmacology (2008) 153, S82–S89; doi:10.1038/sj.bjp.0707570; published online 19 November 2007</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18026129</pmid><doi>10.1038/sj.bjp.0707570</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2008-03, Vol.153 (S1), p.S82-S89
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2268062
source Wiley-Blackwell Journals; PubMed (Medline)
subjects Animals
comparative modelling
CYP2D6
Cytochrome P-450 CYP2D6 - chemistry
Cytochrome P-450 CYP2D6 - drug effects
Cytochrome P-450 Enzyme System - chemistry
Cytochrome P-450 Enzyme System - drug effects
Cytochrome P-450 Enzyme System - metabolism
cytochromes P450
docking
Drug Interactions
drug metabolism
homology modelling
Humans
hypothesis‐driven studies
Models, Molecular
Pharmaceutical Preparations - metabolism
Review
Substrate Specificity
title Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T01%3A37%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insights%20into%20drug%20metabolism%20by%20cytochromes%20P450%20from%20modelling%20studies%20of%20CYP2D6%E2%80%90drug%20interactions&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Mar%C3%A9chal,%20J%E2%80%90D&rft.date=2008-03&rft.volume=153&rft.issue=S1&rft.spage=S82&rft.epage=S89&rft.pages=S82-S89&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.bjp.0707570&rft_dat=%3Cproquest_pubme%3E1438865971%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4916-921cdd75546aa5c1fad020c0cb583240c5e655ae9d2a96cc9ffd3bb03348d6af3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217209781&rft_id=info:pmid/18026129&rfr_iscdi=true